4.4 Article

A structural mapping of mutations causing succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency

期刊

JOURNAL OF INHERITED METABOLIC DISEASE
卷 36, 期 6, 页码 983-987

出版社

WILEY
DOI: 10.1007/s10545-013-9589-z

关键词

-

资金

  1. Canadian Institutes for Health Research [1097737]
  2. Canada Foundation for Innovation
  3. Genome Canada through the Ontario Genomic Institute
  4. GlaxoSmithKline
  5. Karolinska Institutet
  6. Knut and Alice Wallenberg Innovation
  7. Merck and Co., Inc.
  8. Novartis Research Foundation
  9. Swedish Agency for Innovation Systems
  10. Swedish Foundation for Strategic Research
  11. Wellcome Trust
  12. Grants-in-Aid for Scientific Research [24591505] Funding Source: KAKEN

向作者/读者索取更多资源

Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is a rare inherited metabolic disorder of ketone metabolism, characterized by ketoacidotic episodes and often permanent ketosis. To date there are 20 disease-associated alleles on the OXCT1 gene that encodes the mitochondrial enzyme SCOT. SCOT catalyzes the first, rate-limiting step of ketone body utilization in peripheral tissues, by transferring a CoA moiety from succinyl-CoA to form acetoacetyl-CoA, for entry into the tricarboxylic acid cycle for energy production. We have determined the crystal structure of human SCOT, providing a molecular understanding of the reported mutations based on their potential structural effects. An interactive version of this manuscript (which may contain additional mutations appended after acceptance of this manuscript) may be found on the web address: http://www.thesgc.org/jimd/SCOT.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据